Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.

World journal of gastroenterology - 21 Dec 2012

Derbala Moutaz, Rizk Nasser, Shebl Fatima, Alkaabi Saad, Eldweik Nazeeh, John Anil, Sharma Manik, Yaqoob Rafie, Almohanadi Muneera, Butt Mohammed, Alejji Khaled

Abstract excerpt

AIM: To investigate the association between interleukin-28B (IL28B) genotype and response to treatment and hepatic fibrosis in patients with hepatitis C virus (HCV) genotype 4. METHODS: Two hundred and one HCV-genotype 4 patients were included. All patients were treated with Peginterferon alph2a/Ribavirin for 48 wk. End of treatment response (ETR) was defined as loss of detectable serum HCV RNA at the end of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepacivirus
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferons

Share to Interleukins

Share to Liver Cirrhosis

Share to Polyethylene Glycols

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 23323000
DOI: 10.3748/wjg.v18.i47.7003
PMCID: PMC3531686

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.PMID 23323000Read ↗

Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver DiseaseSemantic proximity Read ↗

Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver DiseaseSemantic proximity Read ↗

IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4.Semantic proximity Read ↗

The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.Semantic proximity Read ↗

Single nucleotide polymorphisms rs12979860 and rs8099917 in IL-28B and spontaneous clearance of hepatitis C genotype 4.Semantic proximity Read ↗

Predictive power of Interleukin-28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis.Semantic proximity Read ↗

Host genomics and HCV treatment response.Semantic proximity Read ↗

Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4.Semantic proximity Read ↗

IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection.Semantic proximity Read ↗

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.Semantic proximity Read ↗

IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infectionSemantic proximity Read ↗

Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.